Fiche centre
Michigan Headache and Neurological Institute
Ann Arbor — United States
Essais liés3clinical trials
VilleAnn Arborlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreImport ClinicalTrials.gov
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Dihydroergotamine | Migraine | Phase 3 | NCT03901482 | EMERGE — A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine | COMPLETED |
| neuromodulation for episodic migraine headache | Migraine | Non applicable | NCT01899040 | A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache | COMPLETED |
| EVO756, Dose 1 | Migraine | Phase 2 | NCT07616128 | Study of EVO756 in Adults With Migraine | RECRUITING |